Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Posted in: Medical Condition News | Pharmaceutical News

Tags: Anaphylaxis, Ankylosing Spondylitis, Antibody, Arthritis, Bone, Cancer, Candida, Cardiovascular Disease, Clinical Trial, Crohn’s Disease, Diarrhea, Disability, Drugs, Epidemiology, Exercise, Health Care, Healthcare, Hypersensitivity, Immunization, Immunology, Inflammatory Bowel Disease, Inflammatory Disease, Joint Pain, Light Therapy, Monoclonal Antibody, Neurological Disease, Pain, Placebo, Psoriasis, Psoriatic Arthritis, Respiratory, Respiratory Disease, Rheumatoid Arthritis, Rheumatology, Spine, Spondylitis, Tuberculosis, Urticaria, Vaccines